PET-EMA- docusate sodium enema

País: Estats Units

Idioma: anglès

Font: NLM (National Library of Medicine)

Compra'l ara

Descargar Fitxa tècnica (SPC)
19-11-2018

ingredients actius:

DOCUSATE SODIUM (UNII: F05Q2T2JA0) (DOCUSATE - UNII:M7P27195AG)

Disponible des:

Pegasus Laboratories, Inc

Vía de administración:

RECTAL

tipo de receta:

OTC

indicaciones terapéuticas:

As an aid in maintaining healthy lower bowel function.

Estat d'Autorització:

unapproved drug other

Fitxa tècnica

                                PET-EMA- DOCUSATE SODIUM ENEMA
PEGASUS LABORATORIES, INC
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been_
_approved by FDA. For further information about unapproved drugs,
click here._
----------
12 mL Syringe Enema for Dogs and Cats
Each syringe contains 12 mL of a solution of Dioctyl Sodium
Sulfosuccinate 250 mg in Glycerin, with
Sorbic Acid (as a preservative).
Stimulates the mucosa of the lower bowel and rectum; softens hardened
fecal matter; lubricates the
rectal wall.
USES:
As an aid in maintaining healthy lower bowel function.
DIRECTIONS FOR USE:
Remove tip cap and gently insert nozzle into rectum. If desired,
nozzle can be lubricated prior to
insertion. Slowly depress syringe plunger to express contents.
Treatment may be repeated in one hour if
necessary.
Not for human use
For rectal use only
For veterinary use only
Keep out of reach of children
Store in a cool dry place
PET-EMA
docusate sodium enema
PRODUCT INFORMATION
PRODUCT T YPE
OTC ANIMAL DRUG
ITE M CODE (SOURCE )
NDC:49 427-418
ROUTE OF ADMINISTRATION
RECTAL
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRE NG TH
DO CUSATE SO DIUM (UNII: F0 5Q2T2JA0 ) (DOCUSATE - UNII:M7P2719 5AG)
DOCUSATE SODIUM
250 mg in 12 mL
INACTIVE INGREDIENTS
INGREDIENT NAME
STRE NG TH
SO RBIC ACID (UNII: X0 45WJ9 8 9 B)
GLYCERIN (UNII: PDC6 A3C0 OX)
Pegasus Laboratories, Inc
PRODUCT CHARACTERISTICS
COLOR
blue
S CORE
S HAP E
S IZ E
FLAVOR
IMPRINT CODE
CONTAINS
PACKAG ING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START DATE
MARKETING END DATE
1
NDC:49 427-418 -25
12 in 1 CARTON
1
12 mL in 1 SYRINGE
MARKETING INFORMATION
MARKE TING CATE GORY
APPLICATION NUMBE R OR MONOGRAPH CITATION
MARKE TING START DATE
MARKE TING END DATE
unappro ved drug o ther
0 7/30 /19 9 6
LABELER -
Pegasus Laboratories, Inc (108454760)
REGISTRANT -
Pegasus Laboratories, Inc (108454760)
ESTABLISHMENT
NAME
AD D RE S S
ID/FEI
BUSINE SS OPE RATIONS
Pegasus Labo rato ries, Inc
10 8 45476 0
manufacture, analysis, label
Revised: 11/
                                
                                Llegiu el document complet
                                
                            

Cerqueu alertes relacionades amb aquest producte